News & Updates
Filter by Specialty:
Show Multimedia Only

Sotrovimab may reduce COVID-19 disease progression
23 Nov 2021
byRoshini Claire Anthony
The pan-sarbecovirus monoclonal antibody sotrovimab appears to reduce the risk of COVID-19 disease progression in high-risk patients, according to interim results of the phase III COMET-ICE* trial.
Sotrovimab may reduce COVID-19 disease progression
23 Nov 2021
Hypertension-related CVD rates rise from 1990 to 2019
23 Nov 2021
For three decades, hypertension-related cardiovascular disease (CVD) burden in young adults has substantially rose, with spatiotemporal and sexual heterogeneity, according to a study. Middle-income countries bear the heaviest burden, particularly men.